Aon – Life Science Sector Specific Employee Benefits Survey:
Participating in this targeted survey can give you unique data insight to help:
Benchmark against your industry and non-industry competition to support attraction and retention of talent.
Create a business case backed by data to justify positive benefit changes in your organisation.
Why should organisations participate in this survey?
Aon’s Life Science specific benefits benchmarking survey provides a unique opportunity for organisations to use our data insights to understand how they measure up to their competitors…
The Cambridge Wide Open Day event on Wednesday 12th June is a unique opportunity for all to find out firsthand about the game-changing scientific advancements and technological innovations happening right here in our city, the UK’s science and tech capital.
The cream of Cambridge science and technology is opening its doors to participate in this year’s Be Curious event across the four main science clusters located in:
· Cambridge North including Allia Future Business Kings Edge, Cambridge Science Park, St John’s Innovation Centre, Co-Laboratories, and…
Produced using dry-spun 50 µm Collagen Type I fibers, AMSBIO has introduced the innovative CollaFibR™ additive proven to increase the shape fidelity and biological relevance of bioprinted constructs in hydrogels and bioinks.
In the field of personalized tissue engineering, 3D bioprinting shows immense promise, but the challenge lies in achieving both mechanical durability and biological relevance in the printed constructs.
Acting as a physiologically relevant site for cell attachment within constructs - μCollaFibR™ has been shown to improve the…
SALT LAKE CITY, US and OXFORD, UK – 13 May 2024 – The leading US multi-specialty healthcare center, Metrodora Institute, and pioneering precision medicine company, PrecisionLife, announce the start of recruitment on a cohort of up to 1,000 patients into clinical trials to evaluate new diagnosis and treatment options for ME/CFS, Long Covid, and related disorders. The partners have developed genotypic diagnostic tests that are now being evaluated for their ability to provide clinicians with an accurate view of a patient’s risk of a specific disease. Ultimately, using the molecular profile of…
Arecor Therapeutics plc
(“Arecor” or the “Company”)
ARECOR AND MEDTRONIC DIABETES ESTABLISH COLLABORATION TO DEVELOP A NOVEL THERMOSTABLE INSULIN FOR IMPLANTABLE PUMP DELIVERY
- Medtronic to fund Arecor’s development of Arestat™ enabled novel, high concentration, thermostable insulin, specifically tailored for use in combination with a next-generation implantable pump
Cambridge, UK, 9 May 2024: Arecor Therapeutics plc (AIM: AREC), the biopharmaceutical group advancing today’s therapies to enable healthier lives, today announced a research collaboration with Medtronic plc (NYSE: MDT), a…
DISCOVERY PARK BUSINESS A4P RECEIVES THE KING’S AWARD FOR ENTERPRISE IN INTERNATIONAL TRADE
The most prestigious business award in the United Kingdom.
May 8, 2024, Discovery Park, Sandwich, Kent: A4P, A LabConnect Company, based at Discovery Park, an international centre for science and innovation, in Kent, has been honoured with a King’s Award for Enterprise for International Trade. A4P is one of 252 organisations nationally recognised with a prestigious King’s Award for Enterprise, across four categories - International Trade, Innovation, Sustainable Development and Promoting…
A new report released today by Medicines Discovery Catapult (MDC), in partnership with the UK BioIndustry Association and the Association of the British Pharmaceutical Industry, highlights the impact of recent economic instability on companies in the life sciences sector.
The future health of patients depends on continuing to improve approaches to medicines discovery. However, barriers to investing in companies in the current economic climate threaten to prevent the UK from making some of its biggest breakthroughs.
State of the Discovery Nation (SODN) 2024: ‘Fostering a Dynamic, Sustainable…
Salary insights and trends from over 4,000 global professionals across STEM industries
Wondering how your company’s salary offers compare to your competitors? Are you offering above, or below industry standards? Is your business as diverse, inclusive and fair as it should be?
Or are you a STEM professional seeking to uncover salary trends and expectations for your role?
The exclusive insights from our Global STEM report not only offers the answers you're looking for, but also empowers you to make informed decisions for your career or recruitment strategy.
Download now to discover:
Global…
Broken String Biosciences and the Francis Crick Institute collaborate to advance ALS research
Partnership to expand applications of DNA break-mapping technology and advance understanding of genomic instability in development of the neurodegenerative disease amyotrophic lateral sclerosis
Cambridge and London, UK, 07 May 2024: Broken String Biosciences (“Broken String”), a genomics company driving development of the next generation of more precise, safe, and effective cell and gene therapies, today announced it has entered a research collaboration with the Francis Crick Institute, a world-…
Innovative nanomedicine company, ViaNautis is the latest biotech to join the impressive line-up at Howard Group’s prestigious
Unity Campus
Howard Group continues 2024 leasing success at its fast-growing South Cambridge life science and technology campus.
Scale up biotech ViaNautis is the latest signing at Unity Campus.
Cambridge, 7th May 2024: Leading regional property investor and developer Howard Group, is delighted to announce the latest new letting at its flagship science and technology hub Unity Campus in Cambridge, UK.…